The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

The House passed the “One Big Beautiful Bill Act” on July 3, which includes sweeping changes to healthcare and some pharma-related provisions.

Americans have been clamoring for sensible prescription drug reform for years. With the stroke of his pen, President Donald ...

Risks to BMY include potential for tariffs to raise costs of drugs manufactured outside of the U.S. Moreover, drug pricing ...

Note that some links may require registration or subscription. Princess Kate Middleton shared new details about her recovery ...

Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The pharmaceutical industry’s lobbying muscle scored a high-stakes victory on Monday when the Senate parliamentarian reversed a previous decision and ruled that the Optimizing Research Progress Hope ...